Svenska

Svenska

About us
About us
Research & development
Research & development
Governance
Governance
Investors
Investors
Media
Media
Contact
Contact
- Office
- Investors
- Media

Search for:

Interim report Q3, July–September 2023

November 9, 2023 (Previously November 10, 2023)

Links

Report

Add to calendar

Share

Investors

About us

AlzeCure Pharma in brief
Mission, Vision & Strategy
A word from the CEO
Organization
Career
History

Research & development

Project portfolio
NeuroRestore
Alzstatin
Alzheimer’s disease
Depression
Painless
Pain
Small molecules
Publications
The patients story

Governance

Corporate Governance Reports
General meeting
Nomination Committee
Board of directors
Management team
Remuneration
Auditors
Articles of association

Investors

Share Issue 2024
Capital Markets Day 2023
AlzeCure Pharma on First North Premier Growth Market
Prospectuses
The share
Financial reports
Financial calendar
Presentations and Interviews
Subscribe
Contact

Media

Press releases
Presentations and Interviews
Video gallery
Image bank
Financial calendar
Subscribe
Contact

Contact

Office
Investors
Media

AlzeCure Pharma AB, Hälsovägen 7, SE-141 57 Huddinge, Sweden. Registration number: 559094-8302.

Follow us on LinkedIn

About cookies
Privacy policy for Alzecure Pharma